Abstract
148P HexaBody-OX40: A novel Fcγ receptor crosslinking-independent OX40-targeting antibody, exhibits agonistic activity in vitro and antitumor activity in vivo
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have